Pill Identifier App

shu uemura face architect glow enhancing foundation SPF 26

Dosage form: powder
Ingredients: Octinoxate 0.8g in 14g, Zinc Oxide 0.48g in 14g
Labeler: Cosmelor Ltd
NDC Code: 68570-812

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Facts

Active Ingredients

OCTINOXATE 5.74%, ZINC OXIDE 3.41%

USES: DIRECTIONS:

USES: Helps prevent sunburn. Higher SPF give more sunburn protection.

DIRECTIONS: For sunscreen benefits, apply evenly before sun exposure.

WARNINGS:

WARNINGS: FOR EXTERNAL USE ONLY, NOT TO BE SWALLOWED. AVOID CONTACT WITH EYES. IF CONTACT OCCURS, RINSE EYES THOROUGHLY WITH WATER. DISCONTINUE USE IF SIGNS OF IRRITATION OR RASH APPEAR. IF IRRITATION OR RASH PERSISTS, CONSULT A DOCTOR. KEEP OUT OF REACH OF CHILDREN.

SHU UEMURA FACE ARCHITECT  GLOW ENHANCING FOUNDATION SPF 26
octinoxate zinc oxide powder
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68570-812
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Octinoxate (Octinoxate) Octinoxate0.8 g  in 14 g
Zinc Oxide (Zinc Oxide) Zinc Oxide0.48 g  in 14 g
Packaging
#Item CodePackage Description
1NDC:68570-812-011 CONTAINER (CONTAINER) in 1 CARTON
114 g in 1 CONTAINER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35206/01/2010
Labeler - Cosmelor Ltd (690725908)
Establishment
NameAddressID/FEIOperations
Cosmelor Ltd690725908manufacture

Revised: 06/2010
 
Cosmelor Ltd

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)